Metraipolis › archive › dc_30fc282f6bc3
Physiologically Motivated Sequential Population Modeling of Albumin Trends and Vedolizumab Pharmacokinetics for Pregnancy Dosing Regimen Optimization — Europe PMC PMID:41392610
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41392610
- DOI
- 10.1002/cpt.70145
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T16:05:43.639Z
- SHA-256 of the archived text
48f608ea2f54c825042c45285eaa645f70671743f21e3ad0950d26371a395d69- Stable URL of this page
https://metraipolis.com/documento/dc_30fc282f6bc3
How to cite
Physiologically Motivated Sequential Population Modeling of Albumin Trends and Vedolizumab Pharmacokinetics for Pregnancy Dosing Regimen Optimization — Europe PMC PMID:41392610 — Europe PMC (en), https://europepmc.org/article/MED/41392610 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_30fc282f6bc3 (Metraipolis archive dc_30fc282f6bc3, sha256 48f608ea2f54c825042c45285eaa645f70671743f21e3ad0950d26371a395d69)
BibTeX
@misc{dc30fc282f6bc3,
title = {Physiologically Motivated Sequential Population Modeling of Albumin Trends and Vedolizumab Pharmacokinetics for Pregnancy Dosing Regimen Optimization — Europe PMC PMID:41392610},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41392610},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_30fc282f6bc3; sha256 48f608ea2f54c825042c45285eaa645f70671743f21e3ad0950d26371a395d69},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41392610. Agents can read the archived copy with the MCP tool read_document.